WINCHESTER, ON, Jan. 28 /CNW/ - Natunola Health Biosciences Inc.
(TSX-V:NHI) ("Natunola") is pleased to announce it has signed an agreement with Agriculture and Agri-Food
Canada (AAFC) under the Growing Canadian Agri- Innovations program,
Developing Innovative Agri-Products Initiative (DIAP). Under this
collaborative effort, Natunola is providing $60,000 and AAFC is
investing $150,000 to conduct research. The DIAP initiative encourages
the agricultural-based products sector to develop new or to expand
innovation opportunities by providing access to the scientific and
technical resources to support enhanced profitability and
"This project will enable Natunola and AAFC research scientists to
further research and develop the pilot scale processing for the
production of high-value functional ingredients from flaxseed hull,"
said Dr. Nam Fong Han, President & CEO of Natunola. "The project's main
objective is to develop an economic and feasible yet comprehensive
processing technology to process flaxseed hulls into lignan
concentrates, flaxseed dietary fiber and omega-3 oil components."
Natunola has licensed the flaxseed hull processing technology from AAFC.
About Natunola Health Bioscience Inc.:
Natunola and its manufacturing plant are located in Winchester, Ontario. Natunola is a manufacturer and researcher in the field of flax seed derived
omega-3 fatty acids, flax protein, flax lignans, specialty natural
products, bio-nutrients and functional supplements for human and animal
care markets. Natunola also produces canola oil gels and other natural
ingredients for the cosmetic and personal care industry. Natunola has a
retail health product line under the brand name of Natunola® health's
delight. Natunola was the winner of AAFC's National Canadian Agri-Food
Award of Excellence for Innovation in 2008. www.natunola.com
Some of the statements contained in the release are forward-looking
statements, such as estimates and statements that describe the
Company's future plans, objectives or goals, including words to the
effect that the Company or management expects a stated condition or
result to occur. Since forward-looking statements address future events
and conditions, by their very nature, they involve inherent risks and
uncertainties. Actual results in each case could differ materially from
those currently anticipated in such statements.
The TSX Venture Exchange has not reviewed and does not accept
responsibility for the adequacy or accuracy of this press release.
SOURCE Natunola Health Biosciences Inc.
For further information:
Dr. Nam Fong Han
President & CEO
Natunola Health Biosciences Inc.
661, St Lawrence Street,
Tel (613) 774-9998
Agriculture and Agri-Food Canada